Brookfield Renewable Partners LP
BEP.UN
Emera Inc
EMA
Bank of Nova Scotia
BNS
Choice Properties Real Estate Investment Trust
CHP.UN
Enbridge Inc
ENB
CA Stock MarketDetailed Quotes
GENX Genix Pharmaceuticals Corp
- 0.050
- 0.0000.00%
15min DelayMarket Closed Mar 17 16:00 ET
2.96MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.050Pre Close0.00Turnover0.09052wk High0.00%Turnover Ratio59.22MShares0.02552wk Low--EPS TTM2.39MFloat Cap1.050Historical High0.00P/E (Static)47.83MShs Float0.010Historical Low--EPS LYR0.00%Amplitude--Dividend TTM-2.50P/B1Lot Size--Div YieldTTM
Genix Pharmaceuticals Corp Key Stats
Quarterly+Annual
YOY
| (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -67.19%4.05K | 68 | -62.75%999 | -63.96%2.91K | -95.51%71 | 12.35K | 0 | 2.68K | 8.08K | 1.58K |
| Operating revenue | -67.19%4.05K | --68 | -62.75%999 | -63.96%2.91K | -95.51%71 | --12.35K | --0 | --2.68K | --8.08K | --1.58K |
| Cost of revenue | -69.68%2.75K | 1.07K | -17.32%358 | -83.39%1.31K | -98.28%13 | 9.08K | 0 | 433 | 7.89K | 757 |
| Gross profit | -60.25%1.3K | -1K | -71.50%641 | 747.62%1.6K | -92.97%58 | 3.26K | 0 | 2.25K | 189 | 825 |
| Operating expense | -72.60%242.3K | -64.14%96.94K | -70.96%48.33K | -77.39%49.72K | -79.20%47.32K | -14.26%884.16K | 16.76%270.3K | -32.98%166.44K | -1.40%219.88K | -30.71%227.54K |
| Selling and administrative expenses | -37.51%174.23K | -43.63%59.75K | 74.72%40.16K | -40.53%46.68K | -49.17%43.12K | -34.44%278.83K | 32.20%106K | -72.63%22.99K | 0.13%78.5K | -54.36%84.84K |
| -Selling and marketing expense | -69.96%1.44K | --0 | --0 | 61.16%1.14K | --300 | 148.04%4.8K | 95.92%3.79K | --300 | --708 | --0 |
| -General and administrative expense | -36.95%172.79K | -41.54%59.75K | 77.03%40.16K | -41.46%45.54K | -49.53%42.82K | -35.28%274.03K | 30.63%102.21K | -72.99%22.69K | -0.78%77.79K | -54.36%84.84K |
| Depreciation amortization depletion | -99.79%1.13K | -99.79%283 | -99.79%283 | -99.79%283 | -99.80%283 | -2.97%547.42K | -2.44%135.92K | -4.04%135.92K | -2.99%137.42K | -2.40%138.16K |
| -Depreciation and amortization | -99.79%1.13K | -99.79%283 | -99.79%283 | -99.79%283 | -99.80%283 | -2.97%547.42K | -2.44%135.92K | -4.04%135.92K | -2.99%137.42K | -2.40%138.16K |
| Other operating expenses | 15.60%66.94K | 30.01%36.9K | 4.66%7.88K | -30.56%2.75K | -13.75%3.91K | 38.81%57.91K | 136.44%28.38K | -66.83%7.53K | 34.37%3.96K | 399.23%4.54K |
| Operating profit | 72.64%-241K | 63.77%-97.94K | 70.96%-47.68K | 78.10%-48.12K | 79.15%-47.26K | 14.58%-880.89K | -16.76%-270.3K | 33.89%-164.19K | 1.48%-219.69K | 30.96%-226.72K |
| Net non-operating interest income (expenses) | -132.92%-120.96K | -38.65%-35.47K | -225.09%-32.67K | -227.63%-28.96K | -219.81%-23.86K | -333.29%-51.93K | -484.71%-25.58K | -149.75%-10.05K | -254.94%-8.84K | -580.75%-7.46K |
| Non-operating interest income | -49.72%178 | -55.17%26 | 45.95%54 | -49.22%65 | -74.81%33 | 139.19%354 | 61.11%58 | 0.00%37 | 392.31%128 | 167.35%131 |
| Non-operating interest expense | 131.69%121.14K | 38.44%35.49K | 224.44%32.73K | 223.68%29.02K | 214.73%23.89K | 330.92%52.28K | 481.25%25.64K | 148.39%10.09K | 256.36%8.97K | 563.06%7.59K |
| Other net income (expenses) | 108.34%288.76K | 108.27%287.39K | -117.91%-1.82K | -61.54%-8.87K | 68.94%12.07K | -11,143.79%-3.46M | -17,496.17%-3.47M | 10.14K | -170.14%-5.49K | 179.19%7.14K |
| Gain on sale of security | 75.95%-1.41K | 84.20%-2.79K | -117.91%-1.82K | -61.54%-8.87K | 68.94%12.07K | 80.92%-5.88K | 10.54%-17.67K | --10.14K | -170.14%-5.49K | 179.19%7.14K |
| Special income (charges) | 108.39%290.18K | ---- | ---- | ---- | ---- | ---3.46M | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --3.46M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---472.17K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | --181.99K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 98.33%-73.2K | 104.08%153.98K | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 98.33%-73.2K | 104.08%153.98K | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K |
| Net income continuous operations | 98.33%-73.2K | 104.08%153.98K | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 98.33%-73.2K | 104.08%153.98K | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 98.33%-73.2K | 104.08%153.98K | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K |
| Diluted earnings per share | 0 | 106.39%0.0038 | 49.95%-0.0014 | 63.28%-0.0015 | 74.00%-0.001 | -250.00%-0.07 | -500.00%-0.06 | 34.97%-0.0028 | -2.84%-0.004 | 61.66%-0.0038 |
| Basic earnings per share | 0 | 104.33%0.0026 | 49.95%-0.0014 | 63.28%-0.0015 | 74.00%-0.001 | -250.00%-0.07 | -500.00%-0.06 | 34.97%-0.0028 | -2.84%-0.004 | 61.66%-0.0038 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.